Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Database resources of the national center for biotechnology information.
Nucleic Acids Res. 2022 Jan 7;50(D1):D20-D26. doi: 10.1093/nar/gkab1112.
Nucleic Acids Res. 2022.
PMID: 34850941
Free PMC article.
Database resources of the National Center for Biotechnology Information.
Sayers EW, Beck J, Bolton EE, Bourexis D, Brister JR, Canese K, Comeau DC, Funk K, Kim S, Klimke W, Marchler-Bauer A, Landrum M, Lathrop S, Lu Z, Madden TL, O'Leary N, Phan L, Rangwala SH, Schneider VA, Skripchenko Y, Wang J, Ye J, Trawick BW, Pruitt KD, Sherry ST.
Sayers EW, et al. Among authors: skripchenko y.
Nucleic Acids Res. 2021 Jan 8;49(D1):D10-D17. doi: 10.1093/nar/gkaa892.
Nucleic Acids Res. 2021.
PMID: 33095870
Free PMC article.
Review.
Item in Clipboard
Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer.
Ryan PC, Jakubczak JL, Stewart DA, Hawkins LK, Cheng C, Clarke LM, Ganesh S, Hay C, Huang Y, Kaloss M, Marinov A, Phipps SS, Reddy PS, Shirley PS, Skripchenko Y, Xu L, Yang J, Forry-Schaudies S, Hallenbeck PL.
Ryan PC, et al. Among authors: skripchenko y.
Cancer Gene Ther. 2004 Aug;11(8):555-69. doi: 10.1038/sj.cgt.7700735.
Cancer Gene Ther. 2004.
PMID: 15232601
Item in Clipboard
An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL, Ryan P, Gorziglia M, Clarke L, Hawkins LK, Hay C, Huang Y, Kaloss M, Marinov A, Phipps S, Pinkstaff A, Shirley P, Skripchenko Y, Stewart D, Forry-Schaudies S, Hallenbeck PL.
Jakubczak JL, et al. Among authors: skripchenko y.
Cancer Res. 2003 Apr 1;63(7):1490-9.
Cancer Res. 2003.
PMID: 12670895
Item in Clipboard
Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.
Chen CT, Lin J, Li Q, Phipps SS, Jakubczak JL, Stewart DA, Skripchenko Y, Forry-Schaudies S, Wood J, Schnell C, Hallenbeck PL.
Chen CT, et al. Among authors: skripchenko y.
Hum Gene Ther. 2000 Sep 20;11(14):1983-96. doi: 10.1089/10430340050143417.
Hum Gene Ther. 2000.
PMID: 11020798
Item in Clipboard
Cite
Cite